Amgen reported early Phase 2 data suggesting patients kept weight off with less frequent dosing, a potential differentiator ...
The listed company informed the PSX that Arshad Anis has been appointed as the chairman of the company with effect from today ...
Analysts are forecasting that Injective (INJ) could reach $4.90 by 2030. Feeling confident about this Injective price prediction? You can trade Injective on Coinbase—and if you're new to the platform, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback